Kadimastem receives Hong Kong patent for diabetes therapy technology Sep 4, 2025 07:39AM
NLS Pharmaceutics (NLSP) Launches a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence Jan 28, 2025 07:32AM